ACN vs EOLS · P/E 24, rev $17.60B vs rev $266.3M
Accenture plc (ACN) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the ACN and EOLS stock pages for the full models.
Not investment advice.